Nucleoside cyclic phosphoramidates for the treatment of RNA-dependent RNA viral infection
US8148349B2 · kind B2 · utility
72Cited by
5References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 14, 2007 |
| Grant date | Apr 3, 2012 |
| Priority date | — |
| Expiry date | Apr 2, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides nucleoside cyclic phosphoramidates of formula (I), pharmaceutical compositions comprising the compounds of formula (I) and methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection using the compounds of formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.